Stay updated on LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.

Latest updates to the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, signaling a new version of the page content. This update appears to be a metadata refresh rather than a change to the underlying study details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.5.2 is displayed, and the previous Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check55 days agoChange DetectedThe revision history updates to v3.5.0, replacing the previous v3.4.3 entry.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check90 days agoChange DetectedAdded Revision: v3.4.2; removed the former operating-status notice about government funding and the previous Revision: v3.4.1.SummaryDifference0.3%

- Check97 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, with guidance to check cc.nih.gov and opm.gov. The page revision tag changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.